img

Global and United States Drug Preclinical CRO Services Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and United States Drug Preclinical CRO Services Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and United States Drug Preclinical CRO Services Market
This report focuses on global and United States Drug Preclinical CRO Services market, also covers the segmentation data of other regions in regional level and county level.
The global Drug Preclinical CRO Services revenue was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the review period (2024-2034).
In United States the Drug Preclinical CRO Services revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period 2024-2034.
The global key players of Drug Preclinical CRO Services include LabCorp, IQVIA, PPD, ICON(PRA), Charles River, WuXi AppTec, Pharmaron, Joinn Laboratories and Shanghai Medicilon, etc. The global five biggest players hold a share of % in 2024.
Global Drug Preclinical CRO Services Scope and Market Size
Drug Preclinical CRO Services market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Drug Preclinical CRO Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2034.
For United States market, this report focuses on the Drug Preclinical CRO Services market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.



By Company


LabCorp
IQVIA
PPD
ICON(PRA)
Charles River
WuXi AppTec
Pharmaron
Joinn Laboratories
Shanghai Medicilon
PharmaLegacy Laboratories
ChemPartner PharmaTech
Crown Bioscience
Segment by Type
Pharmacodynamic evaluation service
Pharmacokinetic Evaluation Service

Segment by Application


Biopharmaceutical Company
Scientific Research Unit
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Drug Preclinical CRO Services definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Drug Preclinical CRO Services companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Drug Preclinical CRO Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Preclinical CRO Services revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Drug Preclinical CRO Services Product Introduction
1.2 Global Drug Preclinical CRO Services Outlook 2018 VS 2024 VS 2034
1.2.1 Global Drug Preclinical CRO Services Market Size for the Year 2018-2034
1.2.2 United States Drug Preclinical CRO Services Market Size for the Year 2018-2034
1.3 Drug Preclinical CRO Services Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.3.1 The Market Share of United States Drug Preclinical CRO Services in Global, 2018 VS 2024 VS 2034
1.3.2 The Growth Rate of Drug Preclinical CRO Services Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.4 Drug Preclinical CRO Services Market Dynamics
1.4.1 Drug Preclinical CRO Services Industry Trends
1.4.2 Drug Preclinical CRO Services Market Drivers
1.4.3 Drug Preclinical CRO Services Market Challenges
1.4.4 Drug Preclinical CRO Services Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Drug Preclinical CRO Services by Type
2.1 Drug Preclinical CRO Services Market Segment by Type
2.1.1 Pharmacodynamic evaluation service
2.1.2 Pharmacokinetic Evaluation Service
2.2 Global Drug Preclinical CRO Services Market Size by Type (2018, 2024 & 2034)
2.3 Global Drug Preclinical CRO Services Market Size by Type (2018-2034)
2.4 United States Drug Preclinical CRO Services Market Size by Type (2018, 2024 & 2034)
2.5 United States Drug Preclinical CRO Services Market Size by Type (2018-2034)
3 Drug Preclinical CRO Services by Application
3.1 Drug Preclinical CRO Services Market Segment by Application
3.1.1 Biopharmaceutical Company
3.1.2 Scientific Research Unit
3.2 Global Drug Preclinical CRO Services Market Size by Application (2018, 2024 & 2034)
3.3 Global Drug Preclinical CRO Services Market Size by Application (2018-2034)
3.4 United States Drug Preclinical CRO Services Market Size by Application (2018, 2024 & 2034)
3.5 United States Drug Preclinical CRO Services Market Size by Application (2018-2034)
4 Global Drug Preclinical CRO Services Competitor Landscape by Company
4.1 Global Drug Preclinical CRO Services Market Size by Company
4.1.1 Global Key Companies of Drug Preclinical CRO Services, Ranked by Revenue (2024)
4.1.2 Global Drug Preclinical CRO Services Revenue by Player (2018-2023)
4.2 Global Drug Preclinical CRO Services Concentration Ratio (CR)
4.2.1 Drug Preclinical CRO Services Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Drug Preclinical CRO Services in 2024
4.2.3 Global Drug Preclinical CRO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Drug Preclinical CRO Services Head office and Area Served
4.4 Global Key Players of Drug Preclinical CRO Services, Product and Application
4.5 Global Key Players of Drug Preclinical CRO Services, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Drug Preclinical CRO Services Market Size by Company
4.7.1 Key Players of Drug Preclinical CRO Services in United States, Ranked by Revenue (2024)
4.7.2 United States Drug Preclinical CRO Services Revenue by Players (2021, 2024 & 2023)
5 Global Drug Preclinical CRO Services Market Size by Region
5.1 Global Drug Preclinical CRO Services Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Drug Preclinical CRO Services Market Size by Region (2018-2034)
5.2.1 Global Drug Preclinical CRO Services Market Size by Region: 2018-2023
5.2.2 Global Drug Preclinical CRO Services Market Size by Region (2024-2034)
6 Americas
6.1 Americas Drug Preclinical CRO Services Market Size YoY Growth 2018-2034
6.2 Americas Drug Preclinical CRO Services Market Size by Type
6.2.1 Americas Drug Preclinical CRO Services Market Size by Type (2018-2023)
6.2.2 Americas Drug Preclinical CRO Services Market Size by Type (2024-2034)
6.2.3 Americas Drug Preclinical CRO Services Market Share by Type (2018-2034)
6.3 Americas Drug Preclinical CRO Services Market Size by Application
6.3.1 Americas Drug Preclinical CRO Services Market Size by Application (2018-2023)
6.3.2 Americas Drug Preclinical CRO Services Market Size by Application (2024-2034)
6.3.3 Americas Drug Preclinical CRO Services Market Share by Application (2018-2034)
6.4 Americas Drug Preclinical CRO Services Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Drug Preclinical CRO Services Market Size YoY Growth 2018-2034
7.2 EMEA Drug Preclinical CRO Services Market Size by Type
7.2.1 EMEA Drug Preclinical CRO Services Market Size by Type (2018-2023)
7.2.2 EMEA Drug Preclinical CRO Services Market Size by Type (2024-2034)
7.2.3 EMEA Drug Preclinical CRO Services Market Share by Type (2018-2034)
7.3 EMEA Drug Preclinical CRO Services Market Size by Application
7.3.1 EMEA Drug Preclinical CRO Services Market Size by Application (2018-2023)
7.3.2 EMEA Drug Preclinical CRO Services Market Size by Application (2024-2034)
7.3.3 EMEA Drug Preclinical CRO Services Market Share by Application (2018-2034)
7.4 EMEA Drug Preclinical CRO Services Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Drug Preclinical CRO Services Market Size YoY Growth 2018-2034
8.2 China Drug Preclinical CRO Services Market Size by Type
8.2.1 China Drug Preclinical CRO Services Market Size by Type (2018-2023)
8.2.2 China Drug Preclinical CRO Services Market Size by Type (2024-2034)
8.2.3 China Drug Preclinical CRO Services Market Share by Type (2018-2034)
8.3 China Drug Preclinical CRO Services Market Size by Application
8.3.1 China Drug Preclinical CRO Services Market Size by Application (2018-2023)
8.3.2 China Drug Preclinical CRO Services Market Size by Application (2024-2034)
8.3.3 China Drug Preclinical CRO Services Market Share by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Drug Preclinical CRO Services Market Size YoY Growth 2018-2034
9.2 APAC Drug Preclinical CRO Services Market Size by Type
9.2.1 APAC Drug Preclinical CRO Services Market Size by Type (2018-2023)
9.2.2 APAC Drug Preclinical CRO Services Market Size by Type (2024-2034)
9.2.3 APAC Drug Preclinical CRO Services Market Share by Type (2018-2034)
9.3 APAC Drug Preclinical CRO Services Market Size by Application
9.3.1 APAC Drug Preclinical CRO Services Market Size by Application (2018-2023)
9.3.2 APAC Drug Preclinical CRO Services Market Size by Application (2024-2034)
9.3.3 APAC Drug Preclinical CRO Services Market Share by Application (2018-2034)
9.4 APAC Drug Preclinical CRO Services Market Facts & Figures by Country (2018, 2024 & 2034)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 LabCorp
10.1.1 LabCorp Company Details
10.1.2 LabCorp Business Overview
10.1.3 LabCorp Drug Preclinical CRO Services Introduction
10.1.4 LabCorp Revenue in Drug Preclinical CRO Services Business (2018-2023)
10.1.5 LabCorp Recent Development
10.2 IQVIA
10.2.1 IQVIA Company Details
10.2.2 IQVIA Business Overview
10.2.3 IQVIA Drug Preclinical CRO Services Introduction
10.2.4 IQVIA Revenue in Drug Preclinical CRO Services Business (2018-2023)
10.2.5 IQVIA Recent Development
10.3 PPD
10.3.1 PPD Company Details
10.3.2 PPD Business Overview
10.3.3 PPD Drug Preclinical CRO Services Introduction
10.3.4 PPD Revenue in Drug Preclinical CRO Services Business (2018-2023)
10.3.5 PPD Recent Development
10.4 ICON(PRA)
10.4.1 ICON(PRA) Company Details
10.4.2 ICON(PRA) Business Overview
10.4.3 ICON(PRA) Drug Preclinical CRO Services Introduction
10.4.4 ICON(PRA) Revenue in Drug Preclinical CRO Services Business (2018-2023)
10.4.5 ICON(PRA) Recent Development
10.5 Charles River
10.5.1 Charles River Company Details
10.5.2 Charles River Business Overview
10.5.3 Charles River Drug Preclinical CRO Services Introduction
10.5.4 Charles River Revenue in Drug Preclinical CRO Services Business (2018-2023)
10.5.5 Charles River Recent Development
10.6 WuXi AppTec
10.6.1 WuXi AppTec Company Details
10.6.2 WuXi AppTec Business Overview
10.6.3 WuXi AppTec Drug Preclinical CRO Services Introduction
10.6.4 WuXi AppTec Revenue in Drug Preclinical CRO Services Business (2018-2023)
10.6.5 WuXi AppTec Recent Development
10.7 Pharmaron
10.7.1 Pharmaron Company Details
10.7.2 Pharmaron Business Overview
10.7.3 Pharmaron Drug Preclinical CRO Services Introduction
10.7.4 Pharmaron Revenue in Drug Preclinical CRO Services Business (2018-2023)
10.7.5 Pharmaron Recent Development
10.8 Joinn Laboratories
10.8.1 Joinn Laboratories Company Details
10.8.2 Joinn Laboratories Business Overview
10.8.3 Joinn Laboratories Drug Preclinical CRO Services Introduction
10.8.4 Joinn Laboratories Revenue in Drug Preclinical CRO Services Business (2018-2023)
10.8.5 Joinn Laboratories Recent Development
10.9 Shanghai Medicilon
10.9.1 Shanghai Medicilon Company Details
10.9.2 Shanghai Medicilon Business Overview
10.9.3 Shanghai Medicilon Drug Preclinical CRO Services Introduction
10.9.4 Shanghai Medicilon Revenue in Drug Preclinical CRO Services Business (2018-2023)
10.9.5 Shanghai Medicilon Recent Development
10.10 PharmaLegacy Laboratories
10.10.1 PharmaLegacy Laboratories Company Details
10.10.2 PharmaLegacy Laboratories Business Overview
10.10.3 PharmaLegacy Laboratories Drug Preclinical CRO Services Introduction
10.10.4 PharmaLegacy Laboratories Revenue in Drug Preclinical CRO Services Business (2018-2023)
10.10.5 PharmaLegacy Laboratories Recent Development
10.11 ChemPartner PharmaTech
10.11.1 ChemPartner PharmaTech Company Details
10.11.2 ChemPartner PharmaTech Business Overview
10.11.3 ChemPartner PharmaTech Drug Preclinical CRO Services Introduction
10.11.4 ChemPartner PharmaTech Revenue in Drug Preclinical CRO Services Business (2018-2023)
10.11.5 ChemPartner PharmaTech Recent Development
10.12 Crown Bioscience
10.12.1 Crown Bioscience Company Details
10.12.2 Crown Bioscience Business Overview
10.12.3 Crown Bioscience Drug Preclinical CRO Services Introduction
10.12.4 Crown Bioscience Revenue in Drug Preclinical CRO Services Business (2018-2023)
10.12.5 Crown Bioscience Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Drug Preclinical CRO Services Market Size United States VS Global, CAGR (2018 VS 2024 VS 2034)
Table 2. Drug Preclinical CRO Services Market Trends
Table 3. Drug Preclinical CRO Services Market Drivers
Table 4. Drug Preclinical CRO Services Market Challenges
Table 5. Drug Preclinical CRO Services Market Restraints
Table 6. Global Drug Preclinical CRO Services Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. United States Drug Preclinical CRO Services Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Drug Preclinical CRO Services Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. United States Drug Preclinical CRO Services Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Companies of Drug Preclinical CRO Services, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Drug Preclinical CRO Services Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Drug Preclinical CRO Services Revenue Share by Player, 2018-2023
Table 13. Global Drug Preclinical CRO Services Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drug Preclinical CRO Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Preclinical CRO Services as of 2024)
Table 15. Global Key Players of Drug Preclinical CRO Services, Headquarters and Area Served
Table 16. Global Key Players of Drug Preclinical CRO Services, Product and Application
Table 17. Global Key Players of Drug Preclinical CRO Services, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Drug Preclinical CRO Services in United States, Ranked by Revenue (2024) & (US$ Million)
Table 20. United States Drug Preclinical CRO Services Revenue by Players, (US$ Million), 2021, 2024 & 2023
Table 21. United States Drug Preclinical CRO Services Revenue Share by Players, 2021, 2024 & 2023
Table 22. Global Drug Preclinical CRO Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 23. Global Drug Preclinical CRO Services Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Drug Preclinical CRO Services Market Size Forecast by Region (2024-2034) & (US$ Million)
Table 25. Americas Drug Preclinical CRO Services Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Drug Preclinical CRO Services Market Size by Type (2024-2034) & (US$ Million)
Table 27. Americas Drug Preclinical CRO Services Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Drug Preclinical CRO Services Market Size by Application (2024-2034) & (US$ Million)
Table 29. Americas Drug Preclinical CRO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 30. Americas Drug Preclinical CRO Services Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Drug Preclinical CRO Services Market Size by Country (2024-2034) & (US$ Million)
Table 32. EMEA Drug Preclinical CRO Services Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Drug Preclinical CRO Services Market Size by Type (2024-2034) & (US$ Million)
Table 34. EMEA Drug Preclinical CRO Services Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Drug Preclinical CRO Services Market Size by Application (2024-2034) & (US$ Million)
Table 36. EMEA Drug Preclinical CRO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. EMEA Drug Preclinical CRO Services Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Drug Preclinical CRO Services Market Size by Country (2024-2034) & (US$ Million)
Table 39. China Drug Preclinical CRO Services Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Drug Preclinical CRO Services Market Size by Type (2024-2034) & (US$ Million)
Table 41. China Drug Preclinical CRO Services Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Drug Preclinical CRO Services Market Size by Application (2024-2034) & (US$ Million)
Table 43. China Drug Preclinical CRO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. APAC Drug Preclinical CRO Services Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Drug Preclinical CRO Services Market Size by Type (2024-2034) & (US$ Million)
Table 46. APAC Drug Preclinical CRO Services Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Drug Preclinical CRO Services Market Size by Application (2024-2034) & (US$ Million)
Table 48. APAC Drug Preclinical CRO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 49. APAC Drug Preclinical CRO Services Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Drug Preclinical CRO Services Market Size by Region (2024-2034) & (US$ Million)
Table 51. LabCorp Company Details
Table 52. LabCorp Business Overview
Table 53. LabCorp Drug Preclinical CRO Services Product
Table 54. LabCorp Revenue in Drug Preclinical CRO Services Business (2018-2023) & (US$ Million)
Table 55. LabCorp Recent Development
Table 56. IQVIA Company Details
Table 57. IQVIA Business Overview
Table 58. IQVIA Drug Preclinical CRO Services Product
Table 59. IQVIA Revenue in Drug Preclinical CRO Services Business (2018-2023) & (US$ Million)
Table 60. IQVIA Recent Development
Table 61. PPD Company Details
Table 62. PPD Business Overview
Table 63. PPD Drug Preclinical CRO Services Product
Table 64. PPD Revenue in Drug Preclinical CRO Services Business (2018-2023) & (US$ Million)
Table 65. PPD Recent Development
Table 66. ICON(PRA) Company Details
Table 67. ICON(PRA) Business Overview
Table 68. ICON(PRA) Drug Preclinical CRO Services Product
Table 69. ICON(PRA) Revenue in Drug Preclinical CRO Services Business (2018-2023) & (US$ Million)
Table 70. ICON(PRA) Recent Development
Table 71. Charles River Company Details
Table 72. Charles River Business Overview
Table 73. Charles River Drug Preclinical CRO Services Product
Table 74. Charles River Revenue in Drug Preclinical CRO Services Business (2018-2023) & (US$ Million)
Table 75. Charles River Recent Development
Table 76. WuXi AppTec Company Details
Table 77. WuXi AppTec Business Overview
Table 78. WuXi AppTec Drug Preclinical CRO Services Product
Table 79. WuXi AppTec Revenue in Drug Preclinical CRO Services Business (2018-2023) & (US$ Million)
Table 80. WuXi AppTec Recent Development
Table 81. Pharmaron Company Details
Table 82. Pharmaron Business Overview
Table 83. Pharmaron Drug Preclinical CRO Services Product
Table 84. Pharmaron Revenue in Drug Preclinical CRO Services Business (2018-2023) & (US$ Million)
Table 85. Pharmaron Recent Development
Table 86. Joinn Laboratories Company Details
Table 87. Joinn Laboratories Business Overview
Table 88. Joinn Laboratories Drug Preclinical CRO Services Product
Table 89. Joinn Laboratories Revenue in Drug Preclinical CRO Services Business (2018-2023) & (US$ Million)
Table 90. Joinn Laboratories Recent Development
Table 91. Shanghai Medicilon Company Details
Table 92. Shanghai Medicilon Business Overview
Table 93. Shanghai Medicilon Drug Preclinical CRO Services Product
Table 94. Shanghai Medicilon Revenue in Drug Preclinical CRO Services Business (2018-2023) & (US$ Million)
Table 95. Shanghai Medicilon Recent Development
Table 96. PharmaLegacy Laboratories Company Details
Table 97. PharmaLegacy Laboratories Business Overview
Table 98. PharmaLegacy Laboratories Drug Preclinical CRO Services Product
Table 99. PharmaLegacy Laboratories Revenue in Drug Preclinical CRO Services Business (2018-2023) & (US$ Million)
Table 100. PharmaLegacy Laboratories Recent Development
Table 101. ChemPartner PharmaTech Company Details
Table 102. ChemPartner PharmaTech Business Overview
Table 103. ChemPartner PharmaTech Drug Preclinical CRO Services Product
Table 104. ChemPartner PharmaTech Revenue in Drug Preclinical CRO Services Business (2018-2023) & (US$ Million)
Table 105. ChemPartner PharmaTech Recent Development
Table 106. Crown Bioscience Company Details
Table 107. Crown Bioscience Business Overview
Table 108. Crown Bioscience Drug Preclinical CRO Services Product
Table 109. Crown Bioscience Revenue in Drug Preclinical CRO Services Business (2018-2023) & (US$ Million)
Table 110. Crown Bioscience Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Drug Preclinical CRO Services Product Picture
Figure 2. Global Drug Preclinical CRO Services Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Drug Preclinical CRO Services Market Size 2018-2034 (US$ Million)
Figure 4. United States Drug Preclinical CRO Services Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 5. United States Drug Preclinical CRO Services Market Size 2018-2034 (US$ Million)
Figure 6. United States Drug Preclinical CRO Services Market Share in Global 2018-2034
Figure 7. Drug Preclinical CRO Services Report Years Considered
Figure 8. Product Picture of Pharmacodynamic evaluation service
Figure 9. Product Picture of Pharmacokinetic Evaluation Service
Figure 10. Global Drug Preclinical CRO Services Market Share by Type in 2024 & 2034
Figure 11. Global Drug Preclinical CRO Services Market Size by Type (2018-2034) & (US$ Million)
Figure 12. Global Drug Preclinical CRO Services Market Share by Type (2018-2034)
Figure 13. United States Drug Preclinical CRO Services Market Share by Type in 2024 & 2034
Figure 14. United States Drug Preclinical CRO Services Market Size by Type (2018-2034) & (US$ Million)
Figure 15. United States Drug Preclinical CRO Services Market Share by Type (2018-2034)
Figure 16. Product Picture of Biopharmaceutical Company
Figure 17. Product Picture of Scientific Research Unit
Figure 18. Global Drug Preclinical CRO Services Market Share by Application in 2024 & 2034
Figure 19. Global Drug Preclinical CRO Services Market Size by Application (2018-2034) & (US$ Million)
Figure 20. Global Drug Preclinical CRO Services Market Share by Application (2018-2034)
Figure 21. United States Drug Preclinical CRO Services Market Share by Application in 2024 & 2034
Figure 22. United States Drug Preclinical CRO Services Market Size by Application (2018-2034) & (US$ Million)
Figure 23. United States Drug Preclinical CRO Services Market Share by Application (2018-2034)
Figure 24. The Top 5 and 10 Largest Companies of Drug Preclinical CRO Services in the World: Market Share by Drug Preclinical CRO Services Revenue in 2024
Figure 25. Global Drug Preclinical CRO Services Market Size Market Share by Region: 2018 VS 2024 VS 2034
Figure 26. Global Drug Preclinical CRO Services Market Share by Region (2018-2034)
Figure 27. Americas Drug Preclinical CRO Services Market Size Growth Rate 2018-2034 (US$ Million)
Figure 28. Americas Drug Preclinical CRO Services Market Share by Type (2018-2034)
Figure 29. Americas Drug Preclinical CRO Services Market Share by Application (2018-2034)
Figure 30. United States Drug Preclinical CRO Services Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 31. Canada Drug Preclinical CRO Services Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 32. Mexico Drug Preclinical CRO Services Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 33. Brazil Drug Preclinical CRO Services Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 34. EMEA Drug Preclinical CRO Services Market Size Growth Rate 2018-2034 (US$ Million)
Figure 35. EMEA Drug Preclinical CRO Services Market Share by Type (2018-2034)
Figure 36. EMEA Drug Preclinical CRO Services Market Share by Application (2018-2034)
Figure 37. Europe Drug Preclinical CRO Services Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 38. Middle East Drug Preclinical CRO Services Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 39. Africa Drug Preclinical CRO Services Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 40. China Drug Preclinical CRO Services Market Size Growth Rate 2018-2034 (US$ Million)
Figure 41. China Drug Preclinical CRO Services Market Share by Type (2018-2034)
Figure 42. China Drug Preclinical CRO Services Market Share by Application (2018-2034)
Figure 43. APAC Drug Preclinical CRO Services Market Size Growth Rate 2018-2034 (US$ Million)
Figure 44. APAC Drug Preclinical CRO Services Market Share by Type (2018-2034)
Figure 45. APAC Drug Preclinical CRO Services Market Share by Application (2018-2034)
Figure 46. Japan Drug Preclinical CRO Services Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 47. South Korea Drug Preclinical CRO Services Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 48. China Taiwan Drug Preclinical CRO Services Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 49. Southeast Asia Drug Preclinical CRO Services Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 50. India Drug Preclinical CRO Services Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 51. LabCorp Revenue Growth Rate in Drug Preclinical CRO Services Business (2018-2023)
Figure 52. IQVIA Revenue Growth Rate in Drug Preclinical CRO Services Business (2018-2023)
Figure 53. PPD Revenue Growth Rate in Drug Preclinical CRO Services Business (2018-2023)
Figure 54. ICON(PRA) Revenue Growth Rate in Drug Preclinical CRO Services Business (2018-2023)
Figure 55. Charles River Revenue Growth Rate in Drug Preclinical CRO Services Business (2018-2023)
Figure 56. WuXi AppTec Revenue Growth Rate in Drug Preclinical CRO Services Business (2018-2023)
Figure 57. Pharmaron Revenue Growth Rate in Drug Preclinical CRO Services Business (2018-2023)
Figure 58. Joinn Laboratories Revenue Growth Rate in Drug Preclinical CRO Services Business (2018-2023)
Figure 59. Shanghai Medicilon Revenue Growth Rate in Drug Preclinical CRO Services Business (2018-2023)
Figure 60. PharmaLegacy Laboratories Revenue Growth Rate in Drug Preclinical CRO Services Business (2018-2023)
Figure 61. ChemPartner PharmaTech Revenue Growth Rate in Drug Preclinical CRO Services Business (2018-2023)
Figure 62. Crown Bioscience Revenue Growth Rate in Drug Preclinical CRO Services Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed